These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8084604)

  • 21. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA fingerprint detection of somatic mutations in benign prostatic hyperplasia and prostatic adenocarcinoma.
    Werely CJ; Heyns CF; Van Velden DJ; Van Helden PD
    Genes Chromosomes Cancer; 1996 Sep; 17(1):31-6. PubMed ID: 8889504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic instability of microsatellite sequences in many non-small cell lung carcinomas.
    Shridhar V; Siegfried J; Hunt J; del Mar Alonso M; Smith DI
    Cancer Res; 1994 Apr; 54(8):2084-7. PubMed ID: 8174109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer.
    Matsuyama H; Pan Y; Yoshihiro S; Kudren D; Naito K; Bergerheim US; Ekman P
    Prostate; 2003 Feb; 54(2):103-11. PubMed ID: 12497583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
    Oncogene; 1996 Apr; 12(8):1653-62. PubMed ID: 8622885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
    Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
    Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
    Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
    Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
    Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
    Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetics of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Debruyne FM; Collins VP; van Dekken H; Jenkins RB; Klocker H; Schalken JA; Sesterhenn IA
    Scand J Urol Nephrol Suppl; 1994; 162():65-71; discussion 115-27. PubMed ID: 7817161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
    Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
    Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer.
    Chu LW; Troncoso P; Johnston DA; Liang JC
    Genes Chromosomes Cancer; 2003 Mar; 36(3):303-12. PubMed ID: 12557230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas.
    Strup SE; Pozzatti RO; Florence CD; Emmert-Buck MR; Duray PH; Liotta LA; Bostwick DG; Linehan WM; Vocke CD
    J Urol; 1999 Aug; 162(2):590-4. PubMed ID: 10411092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations.
    Karan D; Schmied BM; Dave BJ; Wittel UA; Lin MF; Batra SK
    Clin Cancer Res; 2001 Nov; 7(11):3472-80. PubMed ID: 11705865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
    BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.